D-tert-Butyl glutamate is a chiral amino acid derivative where the gamma-carboxylic acid group of D-glutamic acid is protected as a tert-butyl ester. This specific stereochemistry (D-configuration) and the acid-labile tert-butyl protecting group make it a valuable non-natural building block in synthetic chemistry. Its primary application is in the pharmaceutical industry as a key chiral intermediate for the synthesis of peptide-based drugs and bioactive molecules. The D-glutamate moiety is a crucial component in various therapeutic agents, including enzyme inhibitors and antimicrobial peptides. The tert-butyl ester protection allows for selective manipulation of the alpha-carboxylic acid during peptide coupling reactions, which is essential for constructing complex peptide sequences with high purity. As a protected form of a non-proteinogenic amino acid, it serves as a specialized synthon in organic synthesis, particularly for introducing the D-glutamate residue into target structures. Its use is critical in medicinal chemistry research for developing novel drug candidates with improved metabolic stability and biological activity.